Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | ELF2 |
Upstream (Parents) |
---|
(<<) BAD → ELF2 |
(<<) CLPP → ELF2 |
(<<) ELOVL1 → ELF2 |
(<<) MAP2K3 → ELF2 |
(<<) PPIB → ELF2 |
(<<) PTRF → ELF2 |
(<<) ROBO3 → ELF2 |
(<<) SEPW1 → ELF2 |
Downstream (Children) |
---|
ELF2 → ACTG1 (>>) |
ELF2 → ADAM17 (>>) |
ELF2 → AIFM1 (>>) |
ELF2 → ATP2B4 (>>) |
ELF2 → ATP7B (>>) |
ELF2 → BCL2L13 (>>) |
ELF2 → CASP9 (>>) |
ELF2 → CDK8 (>>) |
ELF2 → CHI3L1 (>>) |
ELF2 → CHST7 (>>) |
ELF2 → CLCA4 (>>) |
ELF2 → CREB3 (>>) |
ELF2 → CREB3L1 (>>) |
ELF2 → CSNK1D (>>) |
ELF2 → CSTB (>>) |
ELF2 → DDX21 (>>) |
ELF2 → DNAJA1 (>>) |
ELF2 → DNAJA4 (>>) |
ELF2 → DNM3 (>>) |
ELF2 → DUSP6 (>>) |
ELF2 → DVL3 (>>) |
ELF2 → EEF1E1 (>>) |
ELF2 → ENC1 (>>) |
ELF2 → GNB2 (>>) |
ELF2 → GNE (>>) |
ELF2 → GNG4 (>>) |
ELF2 → GRK5 (>>) |
ELF2 → GRK6 (>>) |
ELF2 → HK1 (>>) |
ELF2 → HNF1A (>>) |
ELF2 → HPS6 (>>) |
ELF2 → ITGA3 (>>) |
ELF2 → ITGA5 (>>) |
ELF2 → IVL (>>) |
ELF2 → KCTD12 (>>) |
ELF2 → KRT1 (>>) |
ELF2 → LIPG (>>) |
ELF2 → MAP2K5 (>>) |
ELF2 → MAP3K7 (>>) |
ELF2 → MAP3K8 (>>) |
ELF2 → MAPK13 (>>) |
ELF2 → MAPK14 (>>) |
ELF2 → MIA3 (>>) |
ELF2 → MYCN (>>) |
ELF2 → NCOR1 (>>) |
ELF2 → PAK4 (>>) |
ELF2 → PELO (>>) |
ELF2 → PLD3 (>>) |
ELF2 → PPP1R3D (>>) |
ELF2 → PYGB (>>) |
ELF2 → RAB5B (>>) |
ELF2 → RAB5C (>>) |
ELF2 → RGS20 (>>) |
ELF2 → RPL35 (>>) |
ELF2 → RXRA (>>) |
ELF2 → SERPINB2 (>>) |
ELF2 → SESN1 (>>) |
ELF2 → SPPL2B (>>) |
ELF2 → SPRY4 (>>) |
ELF2 → SRC (>>) |
ELF2 → ST3GAL1 (>>) |
ELF2 → STAT4 (>>) |
ELF2 → STK4 (>>) |
ELF2 → SYK (>>) |
ELF2 → T (>>) |
ELF2 → THBS1 (>>) |
ELF2 → THRA (>>) |
ELF2 → THRB (>>) |
ELF2 → TYK2 (>>) |
ELF2 → UST (>>) |
ELF2 → VPS28 (>>) |
ELF2 → VPS37B (>>) |
ELF2 → YWHAB (>>) |
ELF2 → ZBED2 (>>) |
ELF2 → ZNF215 (>>) |